ProCE Banner Series

JAK Inhibitor Therapy for Alopecia Areata: Ask the Expert Office Hours

The treatment landscape for alopecia areata is shifting with the recent FDA approval of a JAK inhibitor and a robust development pipeline. Join this interactive, ask the expert office hours question and answer session to learn more about the recent advances in  alopecia areata management.

Who Should Attend

The intended target audience for this program is US dermatologists and NP/PAs who treat patients with AA.

All Events

JAK Inhibitor Therapy for Alopecia Areata: Ask the Expert Office Hours

Past Events

December

05

2023

6:00 PM - 6:30 PM Eastern Time (ET)

Virtual

Topics

Interactive question and answer session with an alopecia areata expert dermatologist

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Program Overview
The treatment landscape for alopecia areata is shifting with the recent FDA approval of a JAK inhibitor and a robust development pipeline. Join this interactive, ask the expert office hours question and answer session to learn more about the recent advances in alopecia areata management.

This program is intended for healthcare professionals.

Goal Statement
The goal of this program is for learners to demonstrate and improve their application of knowledge, clinical performance, and confidence in making treatment decisions to optimize the treatment of patients with AA.

Target Audience
The intended target audience for this program is US dermatologists and NP/PAs who treat patients with AA.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Formulate an accurate diagnosis and classification of AA based on multiple disease and patient factors
  • Detail factors that may predict a patient’s positive or negative response to JAK inhibitor therapy for AA
  • Evaluate patients with AA for treatment candidacy with JAK inhibitor therapy

Accreditation

This educational activity is not certified for CME/CE credit.

Acknowledgement

Provided by Clinical Care Options, LLC in partnership with the National Alopecia Areata Foundation.

Supported by an educational grant from Lilly.

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191